MedTrace Logo

Use of GalaFlex in Ptotic Breast

NCT02081157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2023-05-16

No results posted yet for this study

Summary

This study is to assess the physician preference in the clinical performance of the GalaFLEX mesh in soft tissue reinforcement during elective (cosmetic) plastic surgery to the breast, in particular the breast lift mastopexy and breast reduction procedures

Conditions

  • Ptotic Breast

Interventions

DEVICE

GalaFlex Mesh

Sponsors & Collaborators

  • Tepha, Inc.

    collaborator INDUSTRY

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Connie Garrison · Tepha, Inc.

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-25
Primary Completion
2016-11-21
Completion
2016-11-21
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02081157 on ClinicalTrials.gov